Let’s put you in the captains chair! For today. What direction do you want to take us? What makes the most sense?
Some examples: sell the entire Brilacidin platform for a single payment? Does that value make the most sense right now and spare you from lawsuits by investors? Do you sub license to multiple companies? Does that make it difficult to move quick over the next years? Wait for P results and see if you can sell that outright? And then work internally on B and K? There are thousands of scenarios.
I don’t think any serious investor/speculator assumed a quiet period. I also don’t agree with your point that attendance at San Fran means the cda’s “expired” or the other pharmas are no longer interested. Anything is possible — indeed some potential suitors that may have expressed interest in the past could presently be out of the picture. But attendance at the SF conference doesn’t prove or even imply anything to me.
News 
Market Data 
Discover 
